CPHI Annual Report 2019

New modalities, new methods and new thinking to solve old problems
The CPHI Annual Report is a comprehensive and critically important publication that analyses key pharmaceutical trends and innovations forecast by our panel of world class experts. Running as a series of opinions and articles, the CPHI experts call upon their considerable commercial and technical acumen to prophesize the future direction, technologies, opportunities and threats in pharma. It’s an essential read for executives who wish to get a head start today on the shape of tomorrow’s industry.
Contents
CPHI’s Pharma Industry Rankings: Evaluation of current Pharma
Part 1. Innovation, AI and Regulation
Building Quality into Pharma Manufacturing, from Molecule to Medicine: Pharma 4.0
Bikash Chatterjee, President and Chief Science Officer, Pharmatech Associates
Chaos to Continual Improvement: Path to Harmonization
Ajaz Hussein PhD, The National Institute for Pharmaceutical Technology & Education, Inc., USA
Pharmaceutical Quality: Concepts, Misconceptions, Realities and Remedies
Girish Malhotra, President, Epcot International
Part 2. Biologics: Capacity and Biosimilars
Mammalian Biomanufacturing Industry Overview
Dawn M. Ecker, Director of Biotrak Database Services, Bioprocess Technology Group, BDO-USA, LLP
Patricia Seymour, Managing Director, Bioprocess Technology Group, BDO-USA, LLP
Biopharmaceutical Therapies And Biosimilars: Not Your Father’s Medication
Emil W. Ciurczak, Doramaxx Consulting
Part 3. Biologics: Advanced Therapies and China
Trends in Chinese Biopharmaceutical Manufacturing, Contract Manufacturing
Vicky Qing Xia, Bioplan Associates, INC. Rockville, MD
New Developments in Bioprocessing Development & Manufacturing
Michiel E. Ultee, PhD, Ulteemit Bioconsulting, LLC
Part 4. Contract Services, new Modalities and Breakthroughs
Increase in Drug Approvals and Priority Review Shows the Future Is Bright for the CMO Industry
Adam Bradbury Industry Analyst, Pharmsource, a GlobalData product
Patient Centricity: The New Nexus for CDMOs
Stuart E. Needleman, Chief Commercial Officer, Piramal Pharma Solutions
Newer Drugs will Require a New Way of Manufacturing Centred on the Patient
Peter Soelkner, Managing Director, Vetter Pharma International GMBH
Related News
-
News CPHI Sustainability Trend Report 2023: Towards a Greener Future
CPHI releases its 2023 Sustainability Trend Report, working towards a greener future in the pharmaceutical industry. -
News Your Prescription for Marketing Success: Digital Pharma Marketing Toolkit – Free eBook
Download your FREE pharma marketing eBook to learn why it is so important for pharmaceutical marketeers to develop their digital content marketing strategies in order to establish their companies as thought leaders and industry experts. -
News The CPO Starter Pack: Why and When to Bring in a Contract Packaging Partner
Discover the trends affecting the pharmaceutical CPO market, when and why outsourcing may be an enticing option, and what is driving pharmaceutical companies and CDMOs to partner with outsourced packaging and drug delivery organisations. ... -
Sponsored Content 2023 Pharma Trend Outlook: Innovation, Resilience, and Pharma 4.0
Download our 2023 Pharma Trends Outlook report to discover the trends set to shape the pharmaceutical landscape in the new year, with expert opinions and insight from across the pharmaceutical value chain. -
News Trend Report: The True Cost of API Price Rises
Download our Trend Report to discover what the current landscape of APIs and their pricing means for the pharmaceutical industry in the future. -
News US Pharma Market Trends 2021 - Download Report Now!
2020 will go down in history as a pivotal year for the US pharmaceutical manufacturing sector. Firstly, the emergence of the global coronavirus pandemic provided a seismic shock to the industry and forced major rethinking on several lines. And secondly... -
News CPHI post-pandemic report forecasts explosion of contract services growth
During the next 12 months, demand for early-stage contract projects could quickly exceed supply -
News CDMOs benefit from COVID-19 impact, says CPHI Annual Report
CMO growth, however, hampered by innovator approvals from mega-cap pharma.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance